Track KALV and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
KALV - Kalvista Pharmaceuticals Inc (KALV) has a earnings per share of -$0.43, up 56.6% over the past year.
Latest EPS (Actual)
-$0.43
Beat Rate
25.0%
Most Recent
Miss
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| Apr 2026 | -$0.38 | -$0.43 | Miss | -14.27% |
| Mar 2026 | -$0.53 | $0.94 | Beat | +277.36% |
| Dec 2025 | -$0.91 | -$0.92 | Meet | -1.10% |
| Sep 2025 | -$0.90 | -$1.12 | Miss | -24.44% |
| Jul 2025 | -$0.81 | -$0.99 | Miss | -22.22% |
| Mar 2025 | -$0.87 | -$0.92 | Miss | -5.75% |
| Dec 2024 | -$0.91 | -$0.91 | Meet | +0.00% |
| Sep 2024 | -$0.94 | -$0.87 | Beat | +7.45% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.